Transgene Biotek Ltd share price logo

Transgene Biotek Ltd Share Price

3.65

-0.01

(-0.27%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Transgene Biotek Ltd Stock Performance

as on November 19, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹3.59
    ₹3.76
    downward going graph

    1.64%

    Downside

    3.01%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹3.21
    ₹8
    downward going graph

    12.05%

    Downside

    119.18%

    Upside

    downward going graph

Transgene Biotek Ltd share price movements today

Previous Close
₹3.66
Open
₹3.76
Volume
19.09K
Upper Circuit
₹4.39
Lower Circuit
₹2.93
Day's Low - High
₹3.59 - ₹3.76
52 Week Low - High
₹3.21 - ₹8

Transgene Biotek Ltd Historical Returns

1 Month Return
-13.88 %
3 Month Return
-15.86 %
1 Year Return
-45.62 %
3 Year Return
+ 29.79 %
5 Year Return
-22.95 %

Transgene Biotek Ltd Fundamentals

as on November 19, 2025 at 4:01 pm IST

Market Cap

₹27.73 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

-17.43

Return on capital employed (ROCE)

0

Industry PE ratio

51.24

Beta (LTM)

0.39

P/B Ratio

-8.95

Dividend Yield

0

PEG Ratio

102.52

Quarterly Earnings Growth YOY

457.14

EPS (TTM)

-0.09

Sector

Healthcare

Book Value

1.41

Technical Analysis

Transgene Biotek Ltd Stock Valuation

as on November 19, 2025 at 4:01 pm IST

Transgene Biotek Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-227.67x)

December 31, 2024

Today (-17.43x)

November 18, 2025

Industry (51.24x)

November 18, 2025

Highest (13.23x)

October 8, 2018

LowHigh

Today’s Price to Earnings Ratio: -17.43x

Transgene Biotek Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Transgene Biotek Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA27.73-4.59%0.96-1NA
BUY19,251.2158.43%0.533381,669
NA75.6819.34%0.635167
NA30.482.25%0.81NA36
NA63.86-2.66%0.62428

Transgene Biotek Ltd Stock’s Investor Sentiment and Interest

Search interest for Transgene Biotek Ltd Stock has increased by 1% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1% versus previous 30 day period

Transgene Biotek Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
-
-
0.1
0.05
0.05
0.05
0.05
0.06
0.08
0.08
0.05
0.05
Other Income
0.04
0.04
0.04
0.04
0.04
0.05
0.65
0.04
0.04
0.04
-
-
Total Income
0.04
0.04
0.14
0.09
0.09
0.1
0.7
0.1
0.12
0.12
0.05
0.05
Expenses
0.14
0.23
0.22
0.17
0.15
0.31
0.46
0.14
0.17
0.62
0.19
0.13
Operating Profit
-0.14
-0.23
-0.12
-0.12
-0.1
-0.26
-0.41
-0.08
-0.09
-0.54
-0.14
-0.08
Operating Profit Margin %
0%
0%
-120%
-240%
-200%
-520%
-820%
-133.33%
-112.5%
-675%
-280%
-160%
Profit Before Interest, Tax and Depreciation
-0.1
-0.19
-0.08
-0.08
-0.06
-0.22
0.24
-0.03
-0.05
-0.5
-0.14
-0.07
Interest
0.05
0.05
0.03
0.03
0.03
0.03
0.02
0.02
0.02
0.19
0.25
0.26
Depreciation
1.24
1.24
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.05
0.05
Profit Before Tax
-1.39
-1.48
-0.13
-0.13
-0.11
-0.27
0.2
-0.07
-0.09
-0.71
-0.44
-0.38
Profit After Tax
-1.38
-1.47
-0.13
-0.13
-0.12
-0.27
0.2
-0.07
-0.09
-0.71
-0.43
-0.39
Total Net profit including share of profit / Loss from associate company
-1.38
-1.47
-0.13
-0.13
-0.12
-0.27
0.2
-0.07
-0.09
-0.71
-0.43
-0.39
EPS
-0.18
-0.19
-0.02
-0.02
-0.02
-0.04
0.03
-0.01
-0.01
-0.09
-0.06
-0.05
Actual EPS
-0.18
-0.19
-0.02
-0.02
-0.02
-0.04
0.03
-0.01
-0.01
-0.09
-0.06
-0.05
Adjusted EPS
-0.18
-0.19
-0.02
-0.02
-0.02
-0.04
0.03
-0.01
-0.01
-0.09
-0.06
-0.05
Diluted EPS
-0.18
-0.19
-0.02
-0.02
-0.02
-0.04
0.03
-0.01
-0.01
-0.09
-0.06
-0.05

Transgene Biotek Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
0.07
-
0.17
0.09
0.06
0.23
0.26
Other Income
2.04
0.18
0.27
0.21
0.18
0.18
0.78
Total Income
2.11
0.18
0.44
0.3
0.23
0.42
1.04
Expenses
0.76
0.87
0.7
0.55
1.11
0.85
1.38
Operating Profit
-0.69
-0.87
-0.53
-0.46
-1.05
-0.62
-1.12
Operating Profit Margin %
-985.71%
0%
-311.76%
-511.11%
-1750%
-269.57%
-430.77%
Profit Before Interest, Tax and Depreciation
1.35
-0.68
-0.26
-0.25
-0.88
-0.43
-0.34
Interest
0.25
0.38
0.27
0.23
0.18
0.13
0.24
Depreciation
9.89
9.9
9.91
9.92
4.95
0.09
0.09
Profit Before Tax
-8.79
-10.96
-10.44
-10.4
-6.01
-0.65
-0.67
Profit After Tax
-8.79
-10.96
-10.43
-10.4
-6.01
-0.66
-0.68
Total Net profit including share of profit / Loss from associate company
-8.79
-10.96
-10.43
-10.4
-6.01
-0.66
-0.68
EPS
-1.2
-1.45
-1.38
-1.37
-0.79
-0.09
-0.09
Actual EPS
-1.2
-1.45
-1.38
-1.37
-0.79
-0.09
-0.09
Adjusted EPS
-1.2
-1.45
-1.38
-1.37
-0.79
-0.09
-0.09
Diluted EPS
-1.2
-1.45
-1.38
-1.37
-0.79
-0.09
-0.09

Transgene Biotek Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Net Cash from Operating Activities
6.47
0.02
-0.63
-1.74
0.14
0.01
0.1
-
-
Cash Flow from Investing Activities
-
-
3.05
1.81
-
-
-0.1
-0.01
-
Cash Flow from Financing Activities
-
-
-2.37
-
-0.2
-
-
-
-
Net Cash Flow
-
0.02
0.05
-
-0.06
-0.01
-
-0.01
-

Transgene Biotek Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
23.64%
Public
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
76.36%
Total Outstanding Shares
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
7,57,70,000
Total Shareholders
11,432
11,371
11,342
11,360
12,220
12,426
12,766
12,963
13,307
13,583
13,475
13,461

Transgene Biotek Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Transgene Biotek Ltd.

  • Transgene Biotek Ltd Earnings Results

    Transgene Biotek Ltd’s net profit fell -457.14% since last year same period to ₹0.39Cr in the Q2 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 9.3% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Transgene Biotek Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -0.71 Cr → -0.39 Cr (in ₹), with an average increase of 37.7% per quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 70.04% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 67.2% return, outperforming this stock by 112.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 169.9% return, outperforming this stock by 140.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 21.68% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 0.12 Cr → 0.05 Cr (in ₹), with an average decrease of 29.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, Transgene Biotek stock has moved down by -13.9%

About Transgene Biotek Ltd

Transgene Biotek is a public limited company incorporated in Mar.90, engaged in research and development and manufacturing of medical reagents for diagnosis of diseases. It exports nutrients to African countries, Russia, China, Malaysia and the Philippines. The company is implementing a new project at Bollaram Anrich Industrial Area costing Rs.30 crore to set up a new manufacturing facility. The plant will work on four types of products – oral delivery of proteins and peptides, DNA vaccines, fusion proteins and biotherapeutics. The project will be funded by way of preferential offer to Batterymarch Financial Management in USA and other financial institutions.

Revenue: ₹0.05Cr as on September 2025 (Q2 FY26)
Net Profit: ₹0.39Cr as on September 2025 (Q2 FY26)
Chairperson Name: K Koteswara Rao
OrganisationTransgene Biotek Ltd
IndustryHealthcare
CEOK Koteswara Rao
E-voting on sharesClick here to vote

FAQs

What is Transgene Biotek Ltd share price today?

Transgene Biotek Ltd share price today stands at ₹3.65 as on at the close of the market. Transgene Biotek Ltd share today touched a day high of ₹3.76 and a low of ₹3.59.

What is the 52 week high and 52 week low range for Transgene Biotek Ltd share?

Transgene Biotek Ltd touched a 52 week high of ₹8 and a 52 week low of ₹3.21. Transgene Biotek Ltd share price today i.e. is closed at ₹3.65, which is -54.37% down from its 52 week high and 13.71% up from its 52 week low.

What is Transgene Biotek Ltd's market capitalisation today?

Transgene Biotek Ltd market capitalisation is ₹27.73 Cr as on .

How to buy Transgene Biotek Ltd shares?

To buy Transgene Biotek Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 526139 or Transgene Biotek Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Transgene Biotek Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Transgene Biotek Ltd trading volume today?

Transgene Biotek Ltd trading volume is 19.09K as on . This means that 19.09K shares of Transgene Biotek Ltd were bought and sold on the stock market during today's trading session.